Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation

The liver has a huge impact on the functioning of our body and the preservation of homeostasis. It is exposed to many serious diseases, which may lead to the chronic failure of this organ, which is becoming a global health problem today. Currently, the final form of treatment in patients with end-st...

Full description

Bibliographic Details
Main Authors: Marta Budkowska, Ewa Ostrycharz, Natalia Maria Serwin, Łukasz Nazarewski, Elżbieta Cecerska-Heryć, Marta Poręcka, Paweł Rykowski, Radosław Pietrzak, Krzysztof Zieniewicz, Aldona Siennicka, Beata Hukowska-Szematowicz, Barbara Dołęgowska
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/7/2070
_version_ 1797590107829567488
author Marta Budkowska
Ewa Ostrycharz
Natalia Maria Serwin
Łukasz Nazarewski
Elżbieta Cecerska-Heryć
Marta Poręcka
Paweł Rykowski
Radosław Pietrzak
Krzysztof Zieniewicz
Aldona Siennicka
Beata Hukowska-Szematowicz
Barbara Dołęgowska
author_facet Marta Budkowska
Ewa Ostrycharz
Natalia Maria Serwin
Łukasz Nazarewski
Elżbieta Cecerska-Heryć
Marta Poręcka
Paweł Rykowski
Radosław Pietrzak
Krzysztof Zieniewicz
Aldona Siennicka
Beata Hukowska-Szematowicz
Barbara Dołęgowska
author_sort Marta Budkowska
collection DOAJ
description The liver has a huge impact on the functioning of our body and the preservation of homeostasis. It is exposed to many serious diseases, which may lead to the chronic failure of this organ, which is becoming a global health problem today. Currently, the final form of treatment in patients with end-stage (acute and chronic) organ failure is transplantation. The proper function of transplanted organs depends on many cellular processes and immune and individual factors. An enormous role in the process of acceptance or rejection of a transplanted organ is attributed to, among others, the activation of the complement system. The aim of this study was the evaluation of the concentration of selected biomarkers’ complement system activation (C3a, C5a, and sC5b-9 (terminal complement complex)) in the serum of patients before and after liver transplantation (24 h, two weeks). The study was conducted on a group of 100 patients undergoing liver transplantation. There were no complications during surgery and no transplant rejection in any of the patients. All patients were discharged home 2–3 weeks after the surgery. The levels of all analyzed components of the complement system were measured using the ELISA method. Additionally, the correlations of the basic laboratory parameters—C-reactive protein (CRP), hemoglobin (Hb), total bilirubin, alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGTP), and albumin—with the parameters of the complement system (C3a, C5a, and sC5b-9) were determined. In our study, changes in the concentrations of all examined complement system components before and after liver transplantation were observed, with the lowest values before liver transplantation and the highest concentration two weeks after. The direct increase in components of the complement system (C3a, C5a, and sC5b-9) 24 h after transplantation likely affects liver damage after ischemia-reperfusion injury (IRI), while their increase two weeks after transplantation may contribute to transplant tolerance. Increasingly, attention is being paid to the role of C3a and CRP as biomarkers of damage and failure of various organs. From the point of view of liver transplantation, the most interesting correlation in our own research was found exactly between CRP and C3a, 24 h after the transplantation. This study shows that changes in complement activation biomarkers and the correlation with CRP in blood could be a prognostic signature of liver allograft survival or rejection.
first_indexed 2024-03-11T01:15:44Z
format Article
id doaj.art-859ae9208a434cfeac45529226649ddd
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T01:15:44Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-859ae9208a434cfeac45529226649ddd2023-11-18T18:29:03ZengMDPI AGBiomedicines2227-90592023-07-01117207010.3390/biomedicines11072070Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver TransplantationMarta Budkowska0Ewa Ostrycharz1Natalia Maria Serwin2Łukasz Nazarewski3Elżbieta Cecerska-Heryć4Marta Poręcka5Paweł Rykowski6Radosław Pietrzak7Krzysztof Zieniewicz8Aldona Siennicka9Beata Hukowska-Szematowicz10Barbara Dołęgowska11Department of Medical Analytics, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, PolandInstitute of Biology, University of Szczecin, 71-412 Szczecin, PolandDepartment of Laboratory Medicine, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, PolandDepartment of General, Transplant and Liver Surgery, Medical University of Warsaw, ul Banacha 1a, 02-097 Warsaw, PolandDepartment of Laboratory Medicine, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, PolandDepartment of General, Transplant and Liver Surgery, Medical University of Warsaw, ul Banacha 1a, 02-097 Warsaw, PolandDepartment of General, Transplant and Liver Surgery, Medical University of Warsaw, ul Banacha 1a, 02-097 Warsaw, PolandDepartment of General, Transplant and Liver Surgery, Medical University of Warsaw, ul Banacha 1a, 02-097 Warsaw, PolandDepartment of General, Transplant and Liver Surgery, Medical University of Warsaw, ul Banacha 1a, 02-097 Warsaw, PolandDepartment of Medical Analytics, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, PolandInstitute of Biology, University of Szczecin, 71-412 Szczecin, PolandDepartment of Laboratory Medicine, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, PolandThe liver has a huge impact on the functioning of our body and the preservation of homeostasis. It is exposed to many serious diseases, which may lead to the chronic failure of this organ, which is becoming a global health problem today. Currently, the final form of treatment in patients with end-stage (acute and chronic) organ failure is transplantation. The proper function of transplanted organs depends on many cellular processes and immune and individual factors. An enormous role in the process of acceptance or rejection of a transplanted organ is attributed to, among others, the activation of the complement system. The aim of this study was the evaluation of the concentration of selected biomarkers’ complement system activation (C3a, C5a, and sC5b-9 (terminal complement complex)) in the serum of patients before and after liver transplantation (24 h, two weeks). The study was conducted on a group of 100 patients undergoing liver transplantation. There were no complications during surgery and no transplant rejection in any of the patients. All patients were discharged home 2–3 weeks after the surgery. The levels of all analyzed components of the complement system were measured using the ELISA method. Additionally, the correlations of the basic laboratory parameters—C-reactive protein (CRP), hemoglobin (Hb), total bilirubin, alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGTP), and albumin—with the parameters of the complement system (C3a, C5a, and sC5b-9) were determined. In our study, changes in the concentrations of all examined complement system components before and after liver transplantation were observed, with the lowest values before liver transplantation and the highest concentration two weeks after. The direct increase in components of the complement system (C3a, C5a, and sC5b-9) 24 h after transplantation likely affects liver damage after ischemia-reperfusion injury (IRI), while their increase two weeks after transplantation may contribute to transplant tolerance. Increasingly, attention is being paid to the role of C3a and CRP as biomarkers of damage and failure of various organs. From the point of view of liver transplantation, the most interesting correlation in our own research was found exactly between CRP and C3a, 24 h after the transplantation. This study shows that changes in complement activation biomarkers and the correlation with CRP in blood could be a prognostic signature of liver allograft survival or rejection.https://www.mdpi.com/2227-9059/11/7/2070complement systemanaphylatoxinsbiomarkerssC5b-9livertransplantation
spellingShingle Marta Budkowska
Ewa Ostrycharz
Natalia Maria Serwin
Łukasz Nazarewski
Elżbieta Cecerska-Heryć
Marta Poręcka
Paweł Rykowski
Radosław Pietrzak
Krzysztof Zieniewicz
Aldona Siennicka
Beata Hukowska-Szematowicz
Barbara Dołęgowska
Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation
Biomedicines
complement system
anaphylatoxins
biomarkers
sC5b-9
liver
transplantation
title Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation
title_full Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation
title_fullStr Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation
title_full_unstemmed Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation
title_short Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation
title_sort biomarkers of the complement system activation c3a c5a sc5b 9 in serum of patients before and after liver transplantation
topic complement system
anaphylatoxins
biomarkers
sC5b-9
liver
transplantation
url https://www.mdpi.com/2227-9059/11/7/2070
work_keys_str_mv AT martabudkowska biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT ewaostrycharz biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT nataliamariaserwin biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT łukasznazarewski biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT elzbietacecerskaheryc biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT martaporecka biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT pawełrykowski biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT radosławpietrzak biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT krzysztofzieniewicz biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT aldonasiennicka biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT beatahukowskaszematowicz biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation
AT barbaradołegowska biomarkersofthecomplementsystemactivationc3ac5asc5b9inserumofpatientsbeforeandafterlivertransplantation